StockDriftsStockDriftsTop 6 Remedium Capital Partners LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| ORKA | Oruka Therapeutics Inc | 27.31% | 1.57M | $76.8M | +0.85%(+13.25K) | $24.90(+242.26%) | 2026-03-31 | |
| SYRE | Spyre Therapeutics Inc | 26.13% | 1.46M | $73.5M | +0.00%(+0) | $24.76(+249.88%) | 2026-03-31 | |
| DMRA | Damora Therapeutics Inc | 18.84% | 2.05M | $53.0M | +1597.87%(+1.93M) | $23.80(+25.96%) | 2026-03-31 | |
| APGE | Apogee Therapeutics Inc | 17.47% | 583.6K | $49.1M | +0.00%(+0) | $57.61(+130.73%) | 2026-03-31 | |
| JBIO | Jade Biosciences Inc | 7.88% | 1.58M | $22.2M | +0.00%(+0) | $12.03(+78.80%) | 2026-03-31 | |
| CBIO | Crescent Biopharma Inc | 2.36% | 361.3K | $6.6M | +0.00%(+0) | $11.88(+43.92%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +237.14% | +3732.12% |
| Top 20 Holdings Unweighted | +194.22% | +2447.02% |
Sign up free to track Remedium Capital Partners LLC, compare funds side by side, and get alerts the moment positions change.